Spirometrically-defined restrictive ventilatory defect: Population variability and individual determinants

Primary Care Respiratory Journal

Volumn 21, Issue 2, 2012, Pages 187-193

  Soriano, Joan B ^a   Miravitlles, Marc ^b   García Río, Francisco ^c   Muñoz, Luis ^d   Sánchez, Guadalupe ^e   Sobradillo, Victor ^f   Durán, Enric ^g   Guerrero, Dolores ^a   Ancochea, Julio ^h  

^a Fundació Caubet Cimera ^*  (Spain)

^b HOSPITAL CLÍNIC   (Spain)

^c HOSPITAL UNIVERSITARIO LA PAZ   (Spain)

^d HOSPITAL UNIVERSITARIO REINA SOFÍA   (Spain)

^e AUTONOMOUS UNIVERSITY OF MADRID   (Spain)

^f HOSPITAL DE CRUCES   (Spain)

^g INST MUNIC D INVESTIGACIO MEDICA   (Spain)

^h HOSPITAL UNIVERSITARIO DE LA PRINCESA   (Spain)

Author keywords

EPI SCAN; Population; Restrictive ventilatory defect; Spirometry; Variability

Indexed keywords

BRONCHODILATING AGENT;

ACADEMIC ACHIEVEMENT; ADULT; AGED; ARTICLE; BODY MASS; BRONCHUS SECRETION; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DAILY LIFE ACTIVITY; DISEASE ASSOCIATION; DISEASE SEVERITY; DYSPNEA; FEMALE; FORCED EXPIRATORY VOLUME; FORCED VITAL CAPACITY; GEOGRAPHIC DISTRIBUTION; HUMAN; MAJOR CLINICAL STUDY; MALE; MORBIDITY; OBSERVATIONAL STUDY; POPULATION RESEARCH; PRACTICE GUIDELINE; PREVALENCE; QUALITY OF LIFE; QUESTIONNAIRE; RESPIRATORY FUNCTION DISORDER; RESTRICTIVE VENTILATORY DEFECT; SEX DIFFERENCE; SMOKING HABIT; SPAIN; SPIROMETRY; SYMPTOMATOLOGY; WHEEZING;

ACTIVITIES OF DAILY LIVING; CROSS-SECTIONAL STUDIES; FEMALE; FORCED EXPIRATORY VOLUME; HEALTH STATUS; HUMANS; LUNG DISEASES, OBSTRUCTIVE; MALE; MIDDLE AGED; PREVALENCE; QUALITY OF LIFE; SPAIN; SPIROMETRY; VITAL CAPACITY;

EID: 84862704392     PISSN: 14714418     EISSN: 14751534     Source Type: Journal    
DOI: 10.4104/pcrj.2012.00027     Document Type: Article

References (34)

1. Mannino DM, Buist AS, Petty TL, Enright PL, Redd SC. Lung function and mortality in the United States: data from the First National Health and Nutrition Examination Survey follow up study. Thorax 2003;58:388-93. http://dx.doi.org/10.1136/ thorax.58.5.388
2. Ryu JH, Colby TV, Hartman TE. Idiopathic pulmonary fibrosis: current concepts. Mayo Clin Proc 1998;73:1085-101. http://dx.doi.org/10.4065/73.11.1085
3. Mannino DM, Holguin F, Pavlin BI, et al. Risk factors for prevalence of and mortality related to restriction on spirometry: findings from the First National Health and Nutrition Examination Survey and follow-up. Int J Tuberc Lung Dis 2005;9:613e21.
4. Baig IM, Saeed W, Khalil KF. Post-tuberculous chronic obstructive pulmonary disease. J Coll Physicians Surg Pak 2010;20:542-4.
5. Ben Saad H, Khemiss M, Bougmiza I, et al. [Spirometric profile of narghile smokers]. Rev Mal Respir 2009;26:299-314. http://dx.doi.org/10.1016/S0761-8425(09) 72587-2
6. Chakraborty S, Mukherjee S, Roychoudhury S, Siddique S, Lahiri T, Ray MR. Chronic exposures to cholinesterase-inhibiting pesticides adversely affect respiratory health of agricultural workers in India. J Occup Health 2009;51:488-97. http://dx.doi.org/10.1539/joh.L9070
7. Schenker MB, Stoecklin M, Lee K, et al. Pulmonary function and exercise-associated changes with chronic low-level paraquat exposure. Am J Respir Crit Care Med 2004;170:773-9. http://dx.doi.org/10.1164/rccm.200403-266OC
8. Payo J, Perez-Grueso FS, Fernandez-Baillo N, Garcia A. Severe restrictive lung disease and vertebral surgery in a pediatric population. Eur Spine J 2009;18:1905-10. http://dx.doi.org/10.1007/s00586-009-1084-8
9. Ford ES, Mannino DM; National Health and Nutrition Examination Survey Epidemiologic Follow-up Study. Prospective association between lung function and the incidence of diabetes: findings from the National Health and Nutrition Examination Survey Epidemiologic Follow-up Study. Diabetes Care 2004;27:2966-70. http://dx.doi.org/10.2337/diacare.27.12.2966
10. Purdue MP, Gold L, Järvholm B, Alavanja MC, Ward MH, Vermeulen R. Impaired lung function and lung cancer incidence in a cohort of Swedish construction workers. Thorax 2007;62:51-6. http://dx.doi.org/10.1136/thx.2006.064196
11. Miller MR, Hankison J, Brusasco V, et al. Standardisation of spirometry. Eur Respir J 2005;26:319-38. http://dx.doi.org/10.1183/09031936.05.00034805
12. Levy ML, Quanjer PH, Booker R, Cooper BG, Holmes S, Small I. Diagnostic spirometry in primary care: proposed standards for general practice compliant with American Thoracic Society and European Respiratory Society recommendations: a General Practice Airways Group (GPIAG) document. Prim Care Respir J 2009;18:130-47. http://dx.doi.org/10.4104/pcrj.2009.00054
13. Ancochea J, Badiola C, Duran-Tauleria E, et al. [The EPI-SCAN survey to assess the prevalence of chronic obstructive pulmonary disease in Spanish 40-to-80-year-olds: protocol summary.] Estudio EPI-SCAN: resumen del protocolo de un estudio para estimar la prevalencia de EPOC en personas de 40 a 80 años en España. Arch Bronconeumol 2009;45:41-7. http://dx.doi.org/10.1016/j.arbres.2008.06.001
14. a ed.: Comisión de las Comunidades Europeas, 1988.
15. Garrod R, Bestall JCM, Paul EA, Wedzicha JA, Jones PW. Development and validation of a standardized measure of activity of daily living in patients with severe COPD: the London Chest Activity of Daily Living scale (LCADL). Respir Med 2000;94:589-96. http://dx.doi.org/10.1053/rmed.2000.0786
16. Vilaró J, Gimeno E, Sánchez Férez N, et al. Actividades de la vida diaria en pacientes con enfermedad pulmonar obstructiva crónica: validación de la traducción española y análisis comparativo de 2 cuestionarios. Med Clin (Barc) 2007;129:326-32.
17. Charlson ME, Pompei P, Ales KL, et al. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 1987;40:373-83. http://dx.doi.org/10.1016/0021-9681(87)90171-8
18. The EuroQol Group. EuroQol-5D a new facility for measurement of health-related quality of life. Health Policy 1990;16:199-208. http://dx.doi.org/10.1016/0168-8510(90)90421-9
19. Badia X, Roset M, Montserrat S, Herdman M, Segura A. La versión española del EUROQoL: descripción y aplicaciones. Med Clin 1999;112(Suppl 1):79-85
20. Jones PW, Quirk FH, Baveystock CM, Littlejohns P. A self-complete measure of health status for chronic airflow limitation. Am Rev Respir Dis 1992;145:1321-7.
21. Ferrer M, Alonso J, Prieto L, et al. Validity and reliability of the St George's Respiratory Questionnaire after adaptation to a different language and culture: the Spanish example. Eur Respir J 1996;9:1160-6. http://dx.doi.org/10.1183/ 09031936.96.09061160
22. Quanjer Ph, Tammeling G, Cotes J, Pedersen O, Peslin R, Yernault J. Lung volumes and forced ventilatory flows. Report Working Party Standardization of Lung Function Tests, European Community for Steel and Coal. Official Statement of the European Respiratory Society. Eur Respir J 1993;(Suppl 16):5-40.
23. Celli BR, MacNee W, ATS/ERS Task Force. Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper. Eur Respir J 2004;23:932-46. (www.ersnet.org Last updated December 2007).
24. Soriano JB, Zielinski J, Price D. Screening for and early detection of chronic obstructive pulmonary disease. Lancet 2009;374:721-32. http://dx.doi.org/10.1016/S0140-6736(09)61290-3
25. Carr R, Telford V, Waters G. Impact of an educational intervention on the quality of spirometry performance in a general practice: an audit. Prim Care Respir J 2011;22:210-13. http://dx.doi.org/10.4104/pcrj.2011.00006
26. Washko GR, Hunninghake GM, Fernandez IE, et al.; COPDGene Investigators. Lung volumes and emphysema in smokers with interstitial lung abnormalities. N Engl J Med 2011;364:897-906. http://dx.doi.org/10.1056/NEJMoa1007285
27. Scarlata S, Pedone C, Fimognari FL, Bellia V, Forastiere F, Incalzi RA. Restrictive pulmonary dysfunction at spirometry and mortality in the elderly. Respir Med 2008;102:1349-54. http://dx.doi.org/10.1016/j.rmed.2008.02.021
28. Guerra S, Sherrill DL, Venker C, Ceccato CM, Halonen M, Martinez FD. Morbidity and mortality associated with the restrictive spirometric pattern: a longitudinal study. Thorax 2010;65:499-504. http://dx.doi.org/10.1136/thx.2009.126052
29. Menezes AM, Perez-Padilla R, Jardim JR, et al.; PLATINO Team. Chronic obstructive pulmonary disease in five Latin American cities (the PLATINO study): a prevalence study. Lancet 2005;366:1875-81. http://dx.doi.org/10.1016/S0140-6736(05)67632-5
30. Buist AS, McBurnie MA, Vollmer WM, et al.; BOLD Collaborative Research Group. International variation in the prevalence of COPD (the BOLD Study): a population-based prevalence study. Lancet 2007;370:741-50. http://dx.doi.org/10.1016/S0140-6736(07)61377-4
31. Scano G, Innocenti-Bruni G, Stendardi L. Do obstructive and restrictive lung diseases share common underlying mechanisms of breathlessness? Respir Med 2010;104:925-33. http://dx.doi.org/10.1016/j.rmed.2010.02.019
32. Thun MJ, DeLancey JO, Center MM, Jemal A, Ward EM. The global burden of cancer: priorities for prevention. Carcinogenesis 2010;31:100-10. http://dx.doi.org/10.1093/carcin/bgp263
33. Varadi RG, Goldstein RS. Pulmonary rehabilitation for restrictive lung diseases. Chest 2010;137:2247-8. http://dx.doi.org/10.1378/chest.09-1857
34. Culver BH. Obstructive? Restrictive? Or a ventilatory impairment? Chest 2011;140:568-9. http://dx.doi.org/10.1378/chest.11-0935